Carlsmed, Inc. To Participate in Upcoming Investor Conferences
Rhea-AI Summary
Carlsmed (Nasdaq: CARL) will participate in two upcoming virtual investor conferences. Management will attend the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference with one-on-one meetings on Monday, August 10, 2026. Carlsmed will also join the Bank of America SMID Cap Virtual Conference, featuring a fireside chat on Wednesday, August 12, 2026 at 11:00 AM ET, with a live and archived webcast available in the Events & Presentations section of its investor website.
Positive
- None.
Negative
- None.
News Market Reaction – CARL
In the Jul 28 session, CARL gained 7.51%, reflecting a notable positive market reaction. Argus tracked a peak move of +11.4% during that session. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced that management will participate in the following investor conferences:
- 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The Company will host one-on-one meetings on Monday, August 10, 2026.
- Bank of America SMID Cap Virtual Conference. Fireside chat on Wednesday, August 12, 2026, at 11:00 AM ET. A live webcast will be available to registered participants. Investors interested in participating in virtual one-on-one meetings should contact their Bank of America representative.
A live and archived webcast of the Bank of America SMID Cap Virtual Conference will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com